Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2026-02-22 @ 5:07 PM
Study NCT ID:
NCT00198393
Status:
COMPLETED
Last Update Posted:
2010-04-30
First Post:
2005-09-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV
Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IFCT-0301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Pr Jean-François Morère
Old Organization:
Intergroupe Francophone de Cancérologie Thoracique